Kody Technolab appoints Utsav Himanshu Trivedi as Company Secretary

1 min read     Updated on 02 Jul 2026, 05:18 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Kody Technolab Limited appointed Mr. Utsav Himanshu Trivedi as Company Secretary and Compliance Officer effective July 1, 2026, following Board approval. Mr. Trivedi, a qualified Company Secretary with over seven years of experience, will oversee corporate compliance and regulatory filings.

powered bylight_fuzz_icon
44538515

*this image is generated using AI for illustrative purposes only.

Kody Technolab Limited has strengthened its compliance framework by appointing Mr. Utsav Himanshu Trivedi as Company Secretary and Compliance Officer, effective July 1, 2026. The decision, aimed at bolstering corporate governance, follows a recommendation by the Nomination and Remuneration Committee and subsequent approval by the Board of Directors. This strategic move ensures the company adheres to statutory and regulatory requirements under the Companies Act and SEBI regulations.

The appointment was formalized through a regulatory filing submitted to the National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure detailed the rationale and specifics of the new role, emphasizing the importance of robust compliance oversight in the company's operations.

Mr. Utsav Himanshu Trivedi is a law graduate and a qualified Company Secretary with an Associate Company Secretary (ACS) membership number 57058. He brings over seven years of professional experience to the position, specializing in corporate laws, securities laws, and finance. His background includes extensive expertise in corporate compliance, secretarial matters, regulatory filings, and corporate governance.

The terms of Mr. Trivedi's appointment are aligned with the recommendations made by the Nomination and Remuneration Committee. His responsibilities will encompass advising on legal and regulatory matters while ensuring strict adherence to applicable statutory and compliance requirements. This appointment is expected to enhance the company's ability to navigate the complex regulatory landscape effectively.

Key Appointment Details

Detail Information
Name of Appointee Mr. Utsav Himanshu Trivedi
Designation Company Secretary and Compliance Officer
Effective Date July 1, 2026
ACS Number 57058
Experience Over 7 years in corporate and securities laws

Historical Stock Returns for Kody Technolab

1 Day5 Days1 Month6 Months1 Year5 Years
+2.24%+10.71%+35.08%+20.55%+44.04%+528.10%

How will the new compliance framework influence Kody Technolab's strategy for international expansion?

What specific regulatory challenges does Mr. Trivedi's expertise aim to address in the upcoming fiscal year?

Could this appointment signal a shift towards more aggressive M&A activity by improving due diligence capabilities?

Kody Technolab secures exclusive worldwide manufacturing mandate for Medigo robots

2 min read     Updated on 23 Jun 2026, 05:22 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Kody Technolab Limited has signed a tripartite agreement with Falcon Tech Robotics LLC and Sscore AI Tech Diagnostic Limited to establish an exclusive worldwide manufacturing mandate for its Medigo range of AI-powered healthcare screening robots. The three-year agreement, effective June 22, 2026, designates Kody as the manufacturer, Falcon as the exclusive global distributor, and Sscore as the deployment partner, with manufacturing set to commence in H1 of FY 2026-27. The deal targets the growing preventive healthcare market, projected to reach USD 585.6 billion by 2030, and includes a binding minimum purchase framework with provisions for exclusivity and termination upon failure to meet commitments.

powered bylight_fuzz_icon
43667582

*this image is generated using AI for illustrative purposes only.

Kody Technolab Limited has entered into a tripartite agreement with Falcon Tech Robotics LLC and Sscore AI Tech Diagnostic Limited, appointing it as the exclusive worldwide manufacturer of its Medigo range of AI-powered healthcare screening robots. The three-year agreement, effective from June 22, 2026, establishes a commercial framework for the manufacture, supply, distribution, and deployment of these robotic solutions across global markets, targeting a significant unmet need in the healthcare sector.

Agreement Structure and Market Context

Under the agreement, Kody Technolab will manufacture the products on an exclusive worldwide basis, while Falcon Tech Robotics, the company's UAE-based joint venture, will serve as the exclusive global distributor. Sscore AI Tech Diagnostic Limited is responsible for the worldwide deployment and commercialization of the products. Manufacturing and supply of Medigo units are scheduled to commence in H1 of FY 2026-27, supported by a binding minimum purchase framework structured across biannual commercial periods.

The agreement targets the global preventive healthcare market, which industry research projects to grow from approximately USD 268.7 billion in 2023 to USD 585.6 billion by 2030. This expansion addresses the gap where an estimated 4.5 billion people lack full access to essential health services, according to the WHO and World Bank.

The Medigo Product Range

The Medigo range comprises four AI-powered healthcare screening robots designed for clinical-grade preventive screening without dependence on specialized medical staff.

Product Category Description
Medigo Static Stationary robot for fixed deployments in primary health centres and corporate campuses.
Medigo Kids Paediatric screening robot for schools and community child-health programmes.
Medigo Women Women's health screening robot for maternal and reproductive wellness parameters.
Medigo Mobile Moving "health screening ATM" for on-demand deployments in transit hubs and rural areas.

Each unit screens for conditions across metabolic, cardiovascular, infectious, sensory, and mental health categories, generating consolidated reports in the patient’s preferred language and feeding real-time anonymised data into health dashboards.

Strategic Terms and Management Commentary

The agreement includes provisions relating to exclusivity, software support, confidentiality, warranties, intellectual property, and indemnities. It specifies that if Sscore fails to meet minimum purchase commitments, the exclusive manufacturing and supply obligations of Kody and Falcon shall automatically cease, allowing them to engage with third parties. Kody retains the right to continue the agreement on a non-exclusive basis or terminate it upon a 15-day written notice.

Manav Subhashchandra Patel, Managing Director of Kody Technolab Limited, stated that the agreement is a defining moment in the company's journey to scale its healthcare robotics platform globally. Prashant Sawant, Chairman & MD of Sscore AI Tech Diagnostic Limited, highlighted that the Medigo platform offers a uniquely scalable solution to meet critical unmet needs in preventive screening.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0Q7P01013/ae8100cb241042eb.pdf

Historical Stock Returns for Kody Technolab

1 Day5 Days1 Month6 Months1 Year5 Years
+2.24%+10.71%+35.08%+20.55%+44.04%+528.10%

What are the specific capital expenditure requirements for Kody Technolab to scale manufacturing capacity to meet the binding minimum purchase commitments?

How will Kody Technolab manage the operational risks associated with the termination clause if Sscore fails to meet its purchase obligations?

What regulatory approvals will be required across different jurisdictions for the clinical-grade data generated by the Medigo robots?

More News on Kody Technolab

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+44.04%